Nonalcoholic steatohepatitis: an expanded clinical entity.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Gastroenterology

• Publication date

  1994-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0016-5085(94)90235-6PMID 7523217
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group.

  1993cited by this paper
• Differentiation Between Heterozygotes and Homozygotes in Genetic Hemochromatosis by Means of a Histological Hepatic Iron Index: A Study of 192 Cases

  1993cited by this paper
• Measurements of iron status in patients with chronic hepatitis.

  1992cited by this paper
• Confirmation of the efficacy of hepatic tissue iron index in differentiating genetic haemochromatosis from alcoholic liver disease complicated by alcoholic haemosiderosis.

  1991cited by this paper
• Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.

  1991cited by this paper
• Chemotactic activity for human PMN generated during ethanol metabolism by rat hepatocytes: role of glutathione and glutathione peroxidase.

  1990cited by this paper
• Computerized measurement of iron in liver biopsies: A comparison with biochemical iron measurement

  1990cited by this paper
• The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years

  1990cited by this paper
• Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors

  1990cited by this paper
• Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index

  1990cited by this paper
• Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease.

  1990cited by this paper
• Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes?

  1989cited by this paper
• Nonalcoholic steatohepatitis: a study of 49 patients.

  1989cited by this paper
• Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury.

  1988cited by this paper
• The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes.

  1988cited by this paper
• Fatty liver disease in morbid obesity.

  1987cited by this paper
• Fatty liver disease in morbid obesity.

  1987cited by this paper
• Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis.

  1987cited by this paper
• Nonalcoholic fatty liver disease.

  1986cited by this paper
• Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis

  1986cited by this paper
• HLA typing in idiopathic hemochromatosis: Distinction between homozygotes and heterozygotes with biochemical expression

  1981cited by this paper
• Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

  1980cited by this paper
• Tissue iron stores

  1980cited by this paper
• Fatty liver hepatitis and cirrhosis in obese patients.

  1979cited by this paper
• Studies on fatty liver with isolated hepatocytes. I. The action of colchicine, phalloidin, cytochalasin B, and cyclohexamide on protein and triglyceride synthesis and secretion.

  1977cited by this paper
• Considerations on the pathogenesis of fatty liver.

  1966cited by this paper
• FATTY LIVER: CONSIDERATIONS ON THE PATHOGENESIS OF FATTY LIVER

  1966cited by this paper
• INHIBITION OF THE ETHANOL AND CARBON TETRACHLORIDE INDUCED FATTY LIVER BY ANTIOXIDANTS.

  1965cited by this paper

• Deep Learning for Non-Invasive NAFLD Detection and Staging: A Comprehensive Review

  2026cites this paper
• Phenotypic Screening Coupled with AI-Driven Target Deconvolution Identifies α-Terthienyl as a Dual DPP-IV/HSD17β13 Modulator with Efficacy in a Mouse Model of MASLD

  2025cites this paper
• The Green Path to Liver Health: Herbal Solutions for Non-alcoholic Steatohepatitis.

  2025cites this paper
• Metabolic Dysfunction–Associated Steatotic Liver Disease

  2025cites this paper
• Liver Disease and Prevalence of Liver Transplantation in Adults With ZZ Alpha‐1 Antitrypsin Deficiency—A Meta‐Analysis

  2025cites this paper
• Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD): A Narrative Review

  2025cites this paper
• Association between dietary acid load and risk of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes

  2025cites this paper
• Hemostatic alterations in metabolic dysfunction-associated steatotic liver disease (MASLD) and their link to venous thromboembolism (VTE).

  2025cites this paper
• Cytolysis in the practice of a primary care physician

  2025cites this paper
• Efficacy of Intragastric Balloon Placement in Changing Metabolic Dysfunction Associated Fatty Liver Disease

  2025cites this paper
• Resmetirom: A Systematic Review of the Revolutionizing Approach to Non-alcoholic Steatohepatitis Treatment Focusing on Efficacy, Safety, Cost-Effectiveness, and Impact on Quality of Life

  2024cites this paper
• The NRF-2/HO-1 Signaling Pathway: A Promising Therapeutic Target for Metabolic Dysfunction-Associated Steatotic Liver Disease

  2024cites this paper
• Effect of Bariatric Surgery on the Sonographic Grade of Metabolic-Associated Fatty Liver Disease at 12-Month Follow-Up

  2024cites this paper
• Supplementation of Micro- and Macronutrients—A Role of Nutritional Status in Non-Alcoholic Fatty Liver Disease

  2024cites this paper
• Polyphenols improve non‐alcoholic fatty liver disease via gut microbiota: A comprehensive review

  2024cites this paper
• Investigation of cardiovascular risk factors in diabetic and nondiabetic patients with nonalcoholic fatty liver disease

  2024cites this paper
• The effect of soy isoflavones on non-alcoholic fatty liver disease and the level of fibroblast growth factor-21 and fetuin A

  2024cites this paper
• Study of Thyroid Function Tests in Patients with Metabolic Syndrome

  2024cites this paper
• Lycopene Alleviates Endoplasmic Reticulum Stress in Steatohepatitis through Inhibition of the ASK1-JNK Signaling Pathway.

  2024cites this paper
• A functional genomic framework to elucidate novel causal non-alcoholic fatty liver disease genes

  2024cites this paper
• A functional genomic framework to elucidate novel causal metabolic dysfunction–associated fatty liver disease genes

  2024cites this paper
• What Is in a Name: from NAFLD to MAFLD and MASLD—Unraveling the Complexities and Implications

  2023cites this paper
• Proteomic cardiovascular risk assessment in chronic kidney disease.

  2023cites this paper
• Principles of Nutritional Management in Patients with Liver Dysfunction—A Narrative Review

  2023cites this paper
• The effect of melatonin, metformin and ursodeoxycholic acid on non-alcoholic fatty liver disease: A randomized, double-blinded controlled trial

  2023cites this paper
• Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography

  2023cites this paper
• Mass spectrometry based biomarkers for early detection of HCC using a glycoproteomic approach.

  2023cites this paper
• Pharmacological potential of ginseng and ginsenosides in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

  2023cites this paper
• Approach to Elevated Liver Enzymes.

  2023cites this paper
• Bile acid and nonalcoholic steatohepatitis: Molecular insights and therapeutic targets

  2023cites this paper
• La misma enfermedad, nomenclatura cambiante

  2023cites this paper
• Deciphering the liver enigma: distinguishing drug-induced liver injury and metabolic dysfunction-associated steatotic liver disease—a comprehensive narrative review

  2023cites this paper
• Identification of Predictors of Non-alcoholic Steatohepatitis and Its Severity in Individuals Undergoing Bariatric Surgery

  2023cites this paper
• Uncoupling hepatic insulin resistance – hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 diabetes

  2023cites this paper
• Peroxisome Proliferator-Activated Receptor α Has a Protective Effect on Fatty Liver Caused by Excessive Sucrose Intake

  2022cites this paper
• Study of Serum Lipid Profile and Aminotransferases (ALT and AST) in Non-obese, Non-diabetic Nonalcoholic Fatty Liver Disease

  2022cites this paper
• Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different

  2022cites this paper
• Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH

  2022cites this paper
• Relationship between Non-Alcoholic Fatty Liver Disease and Cardiovascular and Metabolic Risk Indices

  2022cites this paper
• Huangqin decoction mitigates hepatic inflammation in high-fat diet-challenged rats by inhibiting TLR4/NF-κB/NLRP3 pathway.

  2022cites this paper
• Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis

  2022cites this paper
• Comparative Study on Serum Hepatic Enzymes between Normal Healthy Adults and Obese People of Rajshahi City

  2022cites this paper
• Association of Metabolomic Change and Treatment Response in Patients with Non-Alcoholic Fatty Liver Disease

  2022cites this paper
• Protective Effects of Tiaoganquzhi Decoction in Treating inflammatory Injury of Nonalcoholic Fatty liver Disease by Promoting CGI-58 and Inhibiting Expression of NLRP3 Inflammasome

  2022cites this paper
• Effect of Vitamin E on Clinical Outcomes in Patients With Non-alcoholic Fatty Liver Disease: A Meta-Analysis

  2022cites this paper
• Evaluation of NAFLD fibrosis, FIB-4 and APRI score in diabetic patients receiving exenatide treatment for non-alcoholic fatty liver disease

  2022cites this paper
• Oxidised low-density lipoprotein (oxLDL) as a biomarker for non-alcoholic fatty liver disease (NAFLD)

  2022cites this paper
• Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss

  2022cites this paper
• Management of Cardiometabolic Complications in Patients With Nonalcoholic Fatty Liver Disease

  2021cites this paper
• CROATIAN GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE

  2021cites this paper
• Steatosis, Steatohepatitis and Related Conditions

  2021cites this paper
• Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille?

  2021cites this paper
• Wilson disease and the differential diagnosis of its hepatic manifestations: a narrative review of clinical, laboratory, and liver histological features

  2021cites this paper
• Conventional ultrasound for diagnosis of hepatic steatosis is better than believed

  2021cites this paper
• The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update

  2021cites this paper
• Hepatic Steatosis in Patients With Single Ventricle and a Fontan Circulation

  2021cites this paper
• From the origin of NASH to the future of metabolic fatty liver disease

  2021cites this paper
• Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD – Reconciling the present with the past

  2021cites this paper
• Fatty liver disease and the risk of erosive esophagitis in a sample of iraqi patients: a cross sectional study

  2021cites this paper
• Efficacy and Safety of Intragastric Balloon (IGB) in Non-alcoholic Fatty Liver Disease (NAFLD): a Comprehensive Review and Meta-analysis

  2021cites this paper
• Tagging incidental finding of fatty liver on ultrasound: A novel intervention to improve early detection of liver fibrosis

  2021cites this paper
• Hepatic lipidosis in fattening turkeys: A review

  2021cites this paper
• The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease

  2021cites this paper
• Iron supplementation regulates the progression of high fat diet induced obesity and hepatic steatosis via mitochondrial signaling pathways

  2021cites this paper
• Established and emerging factors affecting the progression of nonalcoholic fatty liver disease.

  2020cites this paper
• Gibel gantzatsu ez-alkoholikoa, xxi. mendeko osasun-arazoa

  2020cites this paper
• Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2 cm or smaller: A cohort study in Taiwan.

  2020cites this paper
• WOMEN IN THE AGE GROUP OF 20 TO 50 YEARS ARE LESS PRONE TO DEVELOP NAFLD IN KERALA, SOUTH INDIA: A POPULATION BASED STUDY

  2020cites this paper
• Cytokeratin 18 as a non invasive marker in diagnosis of NASH and its usefulness in correlation with disease severity in Egyptian patients

  2020cites this paper
• [Clinical and prognostic value of metabolic disorders in non-alcoholic fatty liver disease].

  2020cites this paper
• Frequency of pre-diabetes, diabetes mellitus in non-alcoholic fatty liver disease.

  2020cites this paper
• Histological grading evaluation of non-alcoholic fatty liver disease after bariatric surgery: a retrospective and longitudinal observational cohort study

  2020cites this paper
• History of Nonalcoholic Fatty Liver Disease

  2020cites this paper
• Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

  2020cites this paper
• Modifiers of liver-related manifestation in the course of NAFLD.

  2020cites this paper
• The natural course of non-alcoholic fatty liver disease

  2020cites this paper
• Targeting ferroptosis alleviates methionine‐choline deficient (MCD)‐diet induced NASH by suppressing liver lipotoxicity

  2020cites this paper
• Investigation of Adiponectin, Leptin, Retinol Binding Protein-4 and Resistin Levels in Non-Diabetic and Non-Obese Patients With Non-Alcoholic Fatty Liver Disease

  2020cites this paper
• The impact of a nutraceutical on insulin resistance in patients with non-alcoholic fatty liver disease: a retrospective observational study

  2020cites this paper
• NAFLD Fibrosis Score or Ultrasonography a Better Practical Aid In Non-Alcoholic Fatty Liver Disease – A Hospital Based Comparative Study

  2019cites this paper
• Hepatic lipidosis: Liver characteristics and acute phase proteins in affected turkeys.

  2019cites this paper
• Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials

  2019cites this paper
• Pretransplant Sarcopenia in Patients With NASH Cirrhosis Does Not Impact Rehospitalization or Mortality

  2019cites this paper
• Clinical and pathophysiological aspects of nonalcoholic fatty liver disease in bariatric surgery

  2019cites this paper
• Low LDL cholesterol-Friend or foe?

  2019cites this paper
• BIOCHEMICAL PROFILE AND VARIOUS TREATMENT MODALITIES OF PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH)

  2019cites this paper
• Review article: iron disturbances in chronic liver diseases other than haemochromatosis – pathogenic, prognostic, and therapeutic implications

  2019cites this paper
• Non‐alcoholic fatty liver disease

  2019cites this paper
• Prevalence of asymptomatic nonalcoholic fatty liver disease in nondiabetic participants: a study from South India

  2019cites this paper
• Dietary and Clinical Profile of Patients with Non-alcoholic Steatohepatitis (NASH)

  2019cites this paper
• The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis

  2019cites this paper
• Development of a mouse iron overload-induced liver injury model and evaluation of the beneficial effects of placenta extract on iron metabolism

  2019cites this paper
• Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist☆

  2019cites this paper
• Liver-related complications and metabolic comorbidities during long-term follow-up of patients with Non-Alcoholic Fatty Liver Disease

  2019cites this paper
• Waist circumference is a Useful Indicator for Non-alcoholic Fatty Liver Disease Patients Visiting Gastro and Liver Care Hospital in Ongole City, Prakasam District, Andhra Pradesh

  2019cites this paper
• A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial

  2019cites this paper
• A Study of Non-Alcoholic Fatty Liver among Adults Using Ultrasonography

  2019cites this paper
• Diagnostic and Treatment Implications of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

  2019cites this paper
• Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges

  2019cites this paper
• Factors associated with nonalcoholic fatty liver disease grades detected by ultrasound at a screening center in Klang Valley, Malaysia.

  2018cites this paper